Emma Rossi Selected Research

Bevacizumab (Avastin)

5/2013

A novel monoclonal antibody to secreted frizzled-related protein 2 inhibits tumor growth.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emma Rossi Research Topics

Disease

3	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 08/2012
3	Neoplasms (Cancer) 01/2020 - 08/2012
1	Thrombocytopenia (Thrombopenia) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Neutropenia 01/2019
1	Triple Negative Breast Neoplasms 05/2013
1	Breast Neoplasms (Breast Cancer) 05/2013
1	Hemangiosarcoma (Angiosarcoma) 05/2013
1	Intraoperative Complications 09/2009

Drug/Important Bio-Agent (IBA)

1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Gemcitabine FDA Link 01/2019
1	BNC 105PIBA 01/2019
1	PlatinumIBA 01/2019
1	transcription factor NF-AT c3IBA 05/2013
1	Bevacizumab (Avastin)FDA Link 05/2013
1	Monoclonal AntibodiesIBA 05/2013
1	CalcineurinIBA 05/2013
1	CateninsIBA 05/2013
1	WD repeat containing planar cell polarity effectorIBA 05/2013

Therapy/Procedure

2	Minimally Invasive Surgical Procedures 01/2021 - 08/2012
1	Elective Surgical Procedures 01/2020
1	Lymph Node Excision (Lymph Node Dissection) 01/2017
1	Laparotomy 08/2012
1	Operative Time 09/2009
1	Blood Transfusion (Blood Transfusions) 09/2009